Apeloa Pharmaceutical Competitors and Similar CompaniesClear all
EyePoint Pharmaceuticals's competitors and similar companies include SciClone Pharmaceuticals.
 EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. |  SciClone Pharmaceuticals SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. | |
Founding Date | Founding Date 1987 | Founding Date 1989 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Watertown, US HQ | Locations Foster City, US HQ |
Employees | Employees 8453% increase | Employees 1102% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $31.4m (FY, 2025) | Revenue (est.) $160.1m (FY, 2016) |
Net income | Net income ($232m) (FY, 2025) | Net income $30.7m (FY, 2016) |
For sources of this data, please see the company profile
View Company Profiles
SciClone Pharmaceuticals
HQ
Foster City, US
Employees
110↓ 2% decrease
SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
View company